Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha

Fig. 2

Factors affecting the efficacy of Peg-IFNα. The OR and 95% CI was plotted for each variable included in the multivariate logistic regression models (sex, female/male; thyroid autoantibody, positive/negative; TD type, clinical or subclinical hyperthyroidism/clinical or subclinical hypothyroidism). CI, confidence interval; OR, odds ratio; Peg-IFNα, pegylated-interferon alpha; TD, thyroid disorder; *p < 0.05; **p < 0.01

Back to article page